Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro R Lowenstein

Showing results (81-90 of 199) with videos related to

Pageof 20
Sort By:
Current Topics in Medicinal Chemistry|October 27, 2005
Combining cytotoxic and immune-mediated gene therapy to treat brain tumorsJames F Curtin, Gwendalyn D King, Marianela Candolfi, et al.
Cancer Research|July 20, 2014
Natural killer cells eradicate galectin-1-deficient glioma in the absence of adaptive immunityGregory J Baker, Peter Chockley, Viveka Nand Yadav, et al.
Human Gene Therapy. Clinical Development|September 7, 2013
Effectiveness and preclinical safety profile of doxycycline to be used "off-label" to induce therapeutic transgene expression in a phase I clinical trial for gliomaNathan VanderVeen, Christopher Paran, Jonathan Krasinkiewicz, et al.
Nature Communications|November 11, 2020
Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapyJason V Gregory, Padma Kadiyala, Robert Doherty, et al.
Circulation|November 26, 2003
Adenovirus-mediated gene transfer of transforming growth factor-beta3, but not transforming growth factor-beta1, inhibits constrictive remodeling and reduces luminal loss after coronary angioplastyPaul A Kingston, Sanjay Sinha, Clare E Appleby, et al.
Neuron Glia Biology|December 18, 2007
Immunological thresholds in neurological gene therapy: highly efficient elimination of transduced cells might be related to the specific formation of immunological synapses between T cells and virus-infected brain cellsCarlos Barcia, Christian Gerdes, Wei-Dong Xiong, et al.
Frontiers in Oncology|October 24, 2022
The complex interactions between the cellular and non-cellular components of the brain tumor microenvironmental landscape and their therapeutic implicationsSyed M Faisal, Andrea Comba, Maria L Varela, et al.
Expert Opinion on Biological Therapy|March 14, 2017
Single vs. combination immunotherapeutic strategies for gliomaMayuri Chandran, Marianela Candolfi, Diana Shah, et al.
Oncoimmunology|February 6, 2018
Melanoma induced immunosuppression is mediated by hematopoietic dysregulationNeha Kamran, Youping Li, Maria Sierra, et al.
Human Gene Therapy Methods|April 9, 2016
Preclinical Efficacy and Safety Profile of Allometrically Scaled Doses of Doxycycline Used to Turn "On" Therapeutic Transgene Expression from High-Capacity Adenoviral Vectors in a Glioma ModelNathan VanderVeen, Nicholas Raja, Elizabeth Yi, et al.
Pageof 20

Showing results (81-90 of 199) with videos related to

Sort By:
Pageof 20
Current Topics in Medicinal Chemistry|October 27, 2005
Combining cytotoxic and immune-mediated gene therapy to treat brain tumorsJames F Curtin, Gwendalyn D King, Marianela Candolfi, et al.
Cancer Research|July 20, 2014
Natural killer cells eradicate galectin-1-deficient glioma in the absence of adaptive immunityGregory J Baker, Peter Chockley, Viveka Nand Yadav, et al.
Human Gene Therapy. Clinical Development|September 7, 2013
Effectiveness and preclinical safety profile of doxycycline to be used "off-label" to induce therapeutic transgene expression in a phase I clinical trial for gliomaNathan VanderVeen, Christopher Paran, Jonathan Krasinkiewicz, et al.
Nature Communications|November 11, 2020
Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapyJason V Gregory, Padma Kadiyala, Robert Doherty, et al.
Circulation|November 26, 2003
Adenovirus-mediated gene transfer of transforming growth factor-beta3, but not transforming growth factor-beta1, inhibits constrictive remodeling and reduces luminal loss after coronary angioplastyPaul A Kingston, Sanjay Sinha, Clare E Appleby, et al.
Neuron Glia Biology|December 18, 2007
Immunological thresholds in neurological gene therapy: highly efficient elimination of transduced cells might be related to the specific formation of immunological synapses between T cells and virus-infected brain cellsCarlos Barcia, Christian Gerdes, Wei-Dong Xiong, et al.
Frontiers in Oncology|October 24, 2022
The complex interactions between the cellular and non-cellular components of the brain tumor microenvironmental landscape and their therapeutic implicationsSyed M Faisal, Andrea Comba, Maria L Varela, et al.
Expert Opinion on Biological Therapy|March 14, 2017
Single vs. combination immunotherapeutic strategies for gliomaMayuri Chandran, Marianela Candolfi, Diana Shah, et al.
Oncoimmunology|February 6, 2018
Melanoma induced immunosuppression is mediated by hematopoietic dysregulationNeha Kamran, Youping Li, Maria Sierra, et al.
Human Gene Therapy Methods|April 9, 2016
Preclinical Efficacy and Safety Profile of Allometrically Scaled Doses of Doxycycline Used to Turn "On" Therapeutic Transgene Expression from High-Capacity Adenoviral Vectors in a Glioma ModelNathan VanderVeen, Nicholas Raja, Elizabeth Yi, et al.
Pageof 20